Janus kinase inhibitors may be an effective treatment to reduce skin depigmentation in vitiligo

Autor: Shannon E. Lohman
Rok vydání: 2020
Předmět:
Zdroj: Clinical Research In Practice: The Journal of Team Hippocrates. 6
ISSN: 2379-4550
DOI: 10.22237/crp/1593561900
Popis: A clinical decision report appraising Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. J Am Acad Dermatol.2017 Jun;76(6):1054-1060.e1. https://doi.org/10.1016/j.jaad.2017.02.049 for a patient with worsening vitiligo.
Databáze: OpenAIRE